Radiation Oncology/Therapy: Page 11

Pluvicto patient response criteria validated
By Will Morton
Doctors now have a reliable approach for determining whether prostate cancer patients are responding to prostate cancer treatment with Pluvicto, according to research published July 11 in Radiology.
July 11, 2023
2023 07 12 00 54 5326 2023 07 12 Recip 20230712000635
FDA clears Coreline's AI-based radiotherapy autocontouring system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared advanced visualization and AI software developer Coreline Soft's AI-based radiotherapy autocontouring system, AView RT ACS.
July 9, 2023
2020 02 24 17 44 7728 Clearance Stamp 400
RaySearch CFO to leave the firm
By AuntMinnie.com staff writers
RaySearch Laboratories' chief financial officer (CFO) Henrik Bergentoft is leaving the company. RaySearch plans to begin recruitment of a permanent CFO immediately.
July 9, 2023
2019 09 17 16 52 3040 Raysearch Astro 2019
Presurgical MRI predicts cancer recurrence after prostatectomy
By Kate Madden Yee
Preprostatectomy, MRI-based staging features perform comparably to postsurgical pathologic staging features for predicting whether prostate cancer will recur, according to a study published July 5 in the American Journal of Roentgenology.
July 5, 2023
2021 01 16 00 14 5464 Prostate Cancer 400
PET/CT radiomics help with multiple myeloma prognosis
By Amerigo Allegretto
Radiomics models based on F-18 FDG-PET/CT imaging features and powered by machine learning can improve prediction for outcomes in multiple myeloma patients, according to research published June 27 in BMC Medical Imaging.
June 29, 2023
2023 06 29 22 24 0671 Multiple Myeloma 400
SNMMI: Tailored prostate cancer treatment improves outcomes
By Kate Madden Yee
Monitoring response during lutetium-177 prostate-specific membrane antigen radioligand therapy improves outcomes, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in Chicago.
June 27, 2023
2023 06 27 20 02 3268 2023 06 28 Snmmi Prostate Treatment Intervals Figure1 20230627205644
SNMMI: Theranostics method targets multiple cancers
By Amerigo Allegretto
A new radionuclide-based agent offers potential as a theranostics approach for targeting multiple cancers, suggest findings presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 27, 2023
2023 06 27 18 37 0239 2023 06 27 Snmmi Pet Mouse 20230627184051
Blue Earth highlights Posluma study results
By AuntMinnie.com staff writers
Blue Earth Diagnostics, a Bracco company, is highlighting results from a study that explored the impact of urinary activity on the interpretation of its flotufolastat F-18 injection (Posluma).
June 26, 2023
2021 01 16 00 14 5464 Prostate Cancer 400
NorthStar manufactures Cu-67 for Clarity Pharmaceuticals
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes is routinely manufacturing copper-67(Cu-67) on its electron accelerators for Clarity Pharmaceuticals.
June 25, 2023
2018 12 11 00 02 7009 Atom Nuclear Lab 400
RefleXion highlights Scintix clinical results at SNMMI
By AuntMinnie.com staff writers
RefleXion is highlighting clinical results from a study conducted on its X1 platform by City of Hope at the Society of Nuclear Medicine and Medical Imaging (SNMMI) meeting in Chicago.
June 25, 2023
2020 03 12 17 01 2761 Reflexion Astro 2019 400
TerraPower, Pantera to collaborate on actinium-225 production
By AuntMinnie.com staff writers
TerraPower Isotopes and Pantera will collaborate to increase the availability of actinium-225, a radioisotope used for cancer treatment.
June 25, 2023
2020 08 20 17 37 8876 Business Handshake Man 400
ASRT elects speaker, vice speaker
By AuntMinnie.com staff writers
The American Society of Radiologic Technologists' (ASRT) House of Delegates has elected a new speaker and vice speaker for 2024.
June 25, 2023
2020 09 01 17 32 7659 Business Woman Handshake 400
Previous Page
Page 11 of 466
Next Page